Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia
J.-P. Després,
A. Golay,
and
L. Sjöström
- 17 Nov, 2005
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
